跳至主要内容
临床试验/NCT05336669
NCT05336669Unknown不适用

Coagulation Profile in Patients Undergoing Coronary Intervention Measured With Activated Clotting Time, Global Thrombosis Test and Platelet Inhibition VerifyNow P2Y12 Test

Centre of Postgraduate Medical Education0 个研究点目标入组 40 人开始时间: 2022年4月30日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
40
主要终点
ACT change

研究概览

简要总结

The activated clotting time (ACT), global thrombosis test (GTT-3), platelet inhibition P2Y12 (VerifyNow) test and serum coagulation factors will be measured in patients undergoing coronary angiography (CA) and percutaneous coronary intervention (PCI).

详细描述

The activated clotting time (ACT), global thrombosis test (GTT-3) and platelet inhibition P2Y12 (VerifyNow) test and serum coagulation factors will be measured in patients undergoing coronary angiography (CA) and percutaneous coronary intervention (PCI) - 20 smoking and 20 non-smoking.The measurements will take place: before coronary angiography (CA), 10 minutes after unfractionated heparin (HNF), 2h after CA, 6h after CA, 30 days after CA

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients scheduled do CA >18 years old

排除标准

  • pregnancy
  • previous treatment with P2Y12 inhibitors, novel oral anticoagulants (NOAC) or warfarin acenocoumarol in last 24 hours

结局指标

主要结局

ACT change

时间窗: Baseline ACT , 10 minutes ACT, 2 hours ACT, 6 hours ACT, 30 days ACT

Activated Clotting Time

GTT-3 change

时间窗: Baseline GTT-3, 10 minutes GTT-3, 2 hours GTT-3, 6 hours GTT-3, 30 days ACT

Global Thrombosis Test

VerifyNow change

时间窗: Baseline VerifyNow, 10 minutes VerifyNow, 2 hours VerifyNow, 6 hours VerifyNow, 30 days ACT

Platelet inhibition P2Y12 test

次要结局

未报告次要终点

研究者

发起方
Centre of Postgraduate Medical Education
申办方类型
Other
责任方
Sponsor

相似试验